• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

J&J stock tumbles after Reuters reports it hid asbestos in talc

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 14, 2018 at 12:52: PM
via After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its talc powder contained cancer-causing asbestos.

article source
 




Top Bottom
Back
Quote